Experimental verification of a traceback phenomenon in prion infection

Journal of Virology

Volumn 84, Issue 7, 2010, Pages 3230-3238

  Kobayashi, Atsushi ^a   Sakuma, Nobuyuki ^a   Matsuura, Yuichi ^b   Mohri, Shirou ^b   Aguzzi, Adriano ^c   Kitamoto, Tetsuyuki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; EPITOPE MAPPING; GENOTYPE; HUMAN; HUMAN TISSUE; INCUBATION TIME; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANIMALS; BLOTTING, WESTERN; BRAIN CHEMISTRY; CREUTZFELDT-JAKOB SYNDROME; GENOTYPE; HUMANS; MICE; MICE, TRANSGENIC; PRPSC PROTEINS;

MUS;

EID: 77949407881     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02387-09     Document Type: Article

References (28)

1. Aguzzi, A., and A. M. Calella. 2009. Prions: protein aggregation and infectious diseases. Physiol. Rev. 89:1105-1152.
2. Asano, M., S. Mohri, J. W. Ironside, M. Ito, N. Tamaoki, and T. Kitamoto. 2006. vCJD prion acquires altered virulence through trans-species infection. Biochem. Biophys. Res. Commun. 342:293-299.
3. Collinge, J., and M. R. Scott. 2007. A general model of prion strains and their pathogenicity. Science 318:930-936.
4. Sc type 2 in Japan. J. Neurol. Neurosurg. Psychiatry 75:485-487.
5. Sc-detection in mouse spleen early at the preclinical stage of scrapie with collagenase-completed tissue homogenization and Sarkosyl-NaCl extraction of PrPSc. Arch. Virol. 141:1863-1874.
6. Kitamoto, T., T. Muramoto, C. Hilbich, K. Beyreuther, and J. Tateishi. 1991. N-terminal sequence of prion protein is also integrated into kuru plaques in patients with Gerstmann-Sträussler syndrome. Brain Res. 545:319-321.
7. Kitamoto, T., R. W. Shin, K. Doh-ura, N. Tomokane, M. Miyazono, T. Muramoto, and J. Tateishi. 1992. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am. J. Pathol. 140:1285-1294.
8. Kitamoto, T., M. Ohta, K. Doh-ura, S. Hitoshi, Y. Terao, and J. Tateishi. 1993. Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Sträussler syndrome. Biochem. Biophys. Res. Commun. 191: 709-714.
9. Kitamoto, T., S. Mohri, J. W. Ironside, I. Miyoshi, T. Tanaka, N. Kitamoto, S. Itohara, N. Kasai, M. Katsuki, J. Higuchi, T. Muramoto, and R. W. Shin. 2002. Follicular dendritic cell of the knock-in mouse provides a new bioassay for human prions. Biochem. Biophys. Res. Commun. 294:280-286.
10. Kobayashi, A., M. Asano, S. Mohri, and T. Kitamoto. 2007. Cross-sequence transmission of sporadic Creutzfeldt-Jakob disease creates a new prion strain. J. Biol. Chem. 282:30022-30028.
11. Kobayashi, A., M. Asano, S. Mohri, and T. Kitamoto. 2009. A traceback phenomenon can reveal the origin of prion infection. Neuropathology 29: 619-624.
12. Korth, C., K. Kaneko, D. Groth, N. Heye, G. Telling, J. Mastrianni, P. Parchi, P. Gambetti, R. Will, J. Ironside, C. Heinrich, P. Tremblay, S. J. DeArmond, and S. B. Prusiner. 2003. Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc. Natl. Acad. Sci. U. S. A. 100:4784-4789.
13. Kretzschmar, H. A., S. Sethi, Z. Földvári, O. Windl, V. Querner, I. Zerr, and S. Poser. 2003. Iatrogenic Creutzfeldt-Jakob disease with florid plaques. Brain Pathol. 13:245-249.
14. Sc types in Creutzfeldt-Jakob disease is not the rule. Lab. Invest. 87:1103-1112.
15. Parchi, P., R. Castellani, S. Capellari, B. Ghetti, K. Young, S. G. Chen, M. Farlow, D. W. Dickson, A. A. F. Sima, J. Q. Trojanowski, R. B. Petersen, and P. Gambetti. 1996. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 39:767-778.
16. Parchi, P., S. Capellari, S. G. Chen, R. B. Petersen, P. Gambetti, N. Kopp, P. Brown, T. Kitamoto, J. Tateishi, A. Giese, and H. Kretzschmar. 1997. Typing prion isoforms. Nature 386:232-234.
17. Parchi, P., A. Giese, S. Capellari, P. Brown, W. Schulz-Schaeffer, O. Windl, I. Zerr, H. Budka, N. Kopp, P. Piccardo, S. Poser, A. Rojiani, N. Streichemberger, J. Julien, C. Vital, B. Ghetti, P. Gambetti, and H. Kretzschmar. 1999. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 46:224-233.
18. Parchi, P., W. Zou, W. Wang, P. Brown, S. Capellari, B. Ghetti, N. Kopp, W. J. Schulz-Schaeffer, H. A. Kretzschmar, M. W. Head, J. W. Ironside, P. Gambetti, and S. G. Chen. 2000. Genetic influence on the structural variations of the abnormal prion protein. Proc. Natl. Acad. Sci. U. S. A. 97:10168-10172.
19. Sc types: an updated classification. Acta Neuropathol. doi:10.1007/s00401-009-0585-1.
20. Peretz, D., R. A. Williamson, G. Legname, Y. Matsunaga, J. Vergara, D. R. Burton, S. J. DeArmond, S. B. Prusiner, and M. R. Scott. 2002. A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron 34:921-932.
21. Polymenidou, M., K. Stoeck, M. Glatzel, M. Vey, A. Bellon, and A. Aguzzi. 2005. Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol. 4:805-814.
22. Polymenidou, M., R. Moos, M. Scott, C. Sigurdson, Y. Z. Shi, B. Yajima, I. Hafner-Bratkovic, R. Jerala, S. Hornemann, K. Wuthrich, A. Bellon, M. Vey, G. Garen, M. N. James, N. Kav, and A. Aguzzi. 2008. The POM monoclonals: a comprehensive set of antibodies to non-overlapping prion protein epitopes. PLoS One 3:e3872.
23. Prusiner, S. B., M. R. Scott, J. P. DeArmond, and F. E. Cohen. 1998. Prion protein biology. Cell 93:337-348.
24. Sc in the same brain. Neurology 53:2173-2176.
25. Saido, T. C., S. Nagao, M. Shiramine, M. Tsukaguchi, H. Sorimachi, H. Murofushi, T. Tsuchiya, H. Ito, and K. Suzuki. 1992. Autolytic transition of μ-calpain upon activation as resolved by antibodies distinguishing between the pre- and post-autolysis forms. J. Biochem. 111:81-86.
26. N3(pE), in senile plaques. Neuron 14:457-466.
27. Taguchi, Y., S. Mohri, J. W. Ironside, T. Muramoto, and T. Kitamoto. 2003. Humanized knock-in mice expressing chimeric prion protein showed varied susceptibility to different human prions. Am. J. Pathol. 163:2585-2593.
28. Yull, H. M., D. L. Ritchie, J. P. M. Langeveld, F. G. van Zijderveld, M. E. Bruce, J. W. Ironside, and M. W. Head. 2006. Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am. J. Pathol. 168:151-157.